Cargando…
Diet and intestinal bacterial overgrowth: Is there evidence?
The intestinal microbiota and its role in health and disease processes have been the subject of several studies. It is known that changes in the intestinal microbiota occur due to several factors, such as the use of medication, age, lifestyle and diseases, which can modify intestinal homeostasis and...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198866/ https://www.ncbi.nlm.nih.gov/pubmed/35801041 http://dx.doi.org/10.12998/wjcc.v10.i15.4713 |
_version_ | 1784727736256823296 |
---|---|
author | Souza, Claudineia Rocha, Raquel Cotrim, Helma Pinchemel |
author_facet | Souza, Claudineia Rocha, Raquel Cotrim, Helma Pinchemel |
author_sort | Souza, Claudineia |
collection | PubMed |
description | The intestinal microbiota and its role in health and disease processes have been the subject of several studies. It is known that changes in the intestinal microbiota occur due to several factors, such as the use of medication, age, lifestyle and diseases, which can modify intestinal homeostasis and lead to excessive growth of bacteria in the small intestine, triggering a clinical condition called small bowel bacterial overgrowth (SIBO). Individuals with SIBO may present gastrointestinal symptoms ranging from nausea, diarrhea and/or constipation, and flatulence to distension and abdominal pain, resulting from poor absorption of nutrients or changes in intestinal permeability. The gold-standard treatment is based on the use of antibiotics to eradicate bacterial overgrowth. Some studies have evaluated diets in the treatment of SIBO; however, the studies are of low methodological quality, making extrapolation of the results to clinical practice unfeasible. Thus, there is still not enough scientific evidence to support a specific type of diet for the treatment of SIBO. |
format | Online Article Text |
id | pubmed-9198866 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-91988662022-07-06 Diet and intestinal bacterial overgrowth: Is there evidence? Souza, Claudineia Rocha, Raquel Cotrim, Helma Pinchemel World J Clin Cases Editorial The intestinal microbiota and its role in health and disease processes have been the subject of several studies. It is known that changes in the intestinal microbiota occur due to several factors, such as the use of medication, age, lifestyle and diseases, which can modify intestinal homeostasis and lead to excessive growth of bacteria in the small intestine, triggering a clinical condition called small bowel bacterial overgrowth (SIBO). Individuals with SIBO may present gastrointestinal symptoms ranging from nausea, diarrhea and/or constipation, and flatulence to distension and abdominal pain, resulting from poor absorption of nutrients or changes in intestinal permeability. The gold-standard treatment is based on the use of antibiotics to eradicate bacterial overgrowth. Some studies have evaluated diets in the treatment of SIBO; however, the studies are of low methodological quality, making extrapolation of the results to clinical practice unfeasible. Thus, there is still not enough scientific evidence to support a specific type of diet for the treatment of SIBO. Baishideng Publishing Group Inc 2022-05-26 2022-05-26 /pmc/articles/PMC9198866/ /pubmed/35801041 http://dx.doi.org/10.12998/wjcc.v10.i15.4713 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Editorial Souza, Claudineia Rocha, Raquel Cotrim, Helma Pinchemel Diet and intestinal bacterial overgrowth: Is there evidence? |
title | Diet and intestinal bacterial overgrowth: Is there evidence? |
title_full | Diet and intestinal bacterial overgrowth: Is there evidence? |
title_fullStr | Diet and intestinal bacterial overgrowth: Is there evidence? |
title_full_unstemmed | Diet and intestinal bacterial overgrowth: Is there evidence? |
title_short | Diet and intestinal bacterial overgrowth: Is there evidence? |
title_sort | diet and intestinal bacterial overgrowth: is there evidence? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198866/ https://www.ncbi.nlm.nih.gov/pubmed/35801041 http://dx.doi.org/10.12998/wjcc.v10.i15.4713 |
work_keys_str_mv | AT souzaclaudineia dietandintestinalbacterialovergrowthisthereevidence AT rocharaquel dietandintestinalbacterialovergrowthisthereevidence AT cotrimhelmapinchemel dietandintestinalbacterialovergrowthisthereevidence |